Lee's Pharmaceutical Establishes New R&D Centre at the Hong Kong Science Park To Bolster the Group's R&D Capabilities 2008.12.17

 
[17 December 2008 – Hong Kong] Lee's Pharmaceutical Holdings Limited (“Lee's Pharmaceutical” or the “Group”, Stock Code: 8221) is an integrated, research-driven and market-oriented pharmaceuticals group in China. Today they announced the establishment of a new research and development centre at the Hong Kong Science Park to further enhance the Group's overall R&D capabilities. This facility, together with the Group's existing mainland R&D centre in Hefei City, Anhui province, will help strengthen the core competitiveness while also satisfying customer demand during the current global economic turmoil.
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD